CSS
TECX

Cubist Systematic Strategies’s Tectonic Therapeutic TECX Stock Holding History

Cubist Systematic Strategies’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4
Closed -$48 – 4408
2023
Q1 		$48 Buy
+4
New +$56 ﹤0.01% 3831
2022
Q3 		– Sell
-1,094
Closed -$12K – 4784
2022
Q2 		$12K Sell
1,094
-781
-42% -$9.21K ﹤0.01% 4256
2022
Q1 		$30K Sell
1,875
-173
-8% -$3.58K ﹤0.01% 3443
2021
Q4 		$95K Sell
2,048
-1,868
-48% -$107K ﹤0.01% 3211
2021
Q3 		$262K Buy
3,916
+1,805
+86% +$148K ﹤0.01% 2434
2021
Q2 		$225K Buy
2,111
+252
+14% +$29.9K ﹤0.01% 2492
2021
Q1 		$283K Buy
+1,859
New +$302K ﹤0.01% 2290
2020
Q1 		– Sell
-727
Closed -$176K – 2508
2019
Q4 		$176K Buy
+727
New +$140K ﹤0.01% 2066

Other funds holding TECX

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's TECX Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Tectonic Therapeutic (TECX) in Q2 2023, closing a stake of 4 shares — an estimated $48 sold.

Cubist Systematic Strategies first reported a position in TECX in Q4 2019 and held it in 8 quarters. The position peaked at $283K in Q1 2021. 40 funds tracked by Wall St. Rank hold TECX as of Q2 2023.

  • Cubist Systematic Strategies reported no remaining Tectonic Therapeutic position as of Q2 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 4 Tectonic Therapeutic shares in Q2 2023, an estimated $48.
  • Cubist Systematic Strategies first reported a position in Tectonic Therapeutic in Q4 2019 and held it in 8 quarters.
  • Cubist Systematic Strategies's Tectonic Therapeutic position peaked at $283K in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.